Journal article
Incidence, Clearance, and Persistence of Anal Human Papillomavirus in Men Who Have Sex with Men Living with Human Immunodeficiency Virus: Implications for Human Papillomavirus Vaccination
JJ Ong, S Walker, A Grulich, J Hoy, TRH Read, C Bradshaw, M Chen, SM Garland, A Cornall, R Hillman, DJ Templeton, J Hocking, B Eu, B Tee, EPF Chow, CK Fairley
Sexually Transmitted Diseases | Published : 2019
Abstract
Background Men who have sex with men living with human immunodeficiency virus have a high risk of anal cancer. We estimate the likely benefit of human papillomavirus (HPV) vaccination among participants of the Anal Cancer Examination study. Methods Anal swabs were collected for the detection and genotyping of anal HPV DNA by linear array (Roche Diagnostics) in this 2-year multicenter prospective cohort. We calculated the proportion of men, stratified by age, without detectable vaccine type-specific DNA. Results Overall, 255 men, with a median age of 50 years (interquartile range, 44-56 years) contributed 488.9 person-years of follow-up. After 2 years of follow-up, 149 (58%; 95% confidence in..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by the Australian National Health and Medical Research Council (NHMRC) Program grant (568971). J.J.O., E.P.F.C., and T.R.H.R. are supported by the Australian NHMRC Early Career Fellowships [grant numbers J.J.O., 1104781; E.P.F.C., 1091226; T.R.H.R., 1091536].